Montag & Associates’s Barclays BCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-111
Closed -$2.29K 979
2025
Q3
$2.29K Buy
+111
New +$2.2K ﹤0.01% 901
2025
Q1
Sell
-542
Closed -$8.11K 991
2024
Q4
$7.2K Sell
542
-100
-16% -$1.3K ﹤0.01% 810
2024
Q3
$7.8K Hold
642
﹤0.01% 829
2024
Q2
$6.88K Sell
642
-235
-27% -$2.44K ﹤0.01% 802
2024
Q1
$8.52K Hold
877
﹤0.01% 772
2023
Q4
$6.91K Buy
877
+122
+16% +$879 ﹤0.01% 801
2023
Q3
$5.88K Hold
755
﹤0.01% 793
2023
Q2
$5.93K Hold
755
﹤0.01% 809
2023
Q1
$5.43K Buy
755
+205
+37% +$1.69K ﹤0.01% 810
2022
Q4
$4.29K Buy
+550
New +$4.01K ﹤0.01% 829

Other funds holding BCS

Montag & Associates's BCS Position: Q4 2025 in Review

Montag & Associates sold out of Barclays (BCS) in Q4 2025, closing a stake of 111 shares — an estimated $2.29K sold.

Montag & Associates first reported a position in BCS in Q4 2022 and held it in 10 quarters. The position peaked at $8.52K in Q1 2024. 507 funds tracked by Wall St. Rank hold BCS as of Q4 2025.

  • Montag & Associates reported no remaining Barclays position as of Q4 2025 after selling out during the quarter.
  • Montag & Associates sold 111 Barclays shares in Q4 2025, an estimated $2.29K.
  • Montag & Associates first reported a position in Barclays in Q4 2022 and held it in 10 quarters.
  • Montag & Associates's Barclays position peaked at $8.52K in Q1 2024.
  • 507 funds tracked by Wall St. Rank held Barclays as of Q4 2025.

Based on Montag & Associates's 13F filing for Q4 2025, filed 2 Feb 2026.